Document is current

Any future updates will be listed below

Nivolumab Combined with Chemotherapy in FGFR2 and PD-L1 Co-Expressing Metastatic Gastric Cancer: A Prospective Phase 2 NIVOFGFR2 Study

Crossref DOI link: https://doi.org/10.1007/s12029-025-01172-5

Published Online: 2025-01-11

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark